ID   NS0bcl-2
AC   CVCL_DD16
SY   NSObcl-2; NS0 Bcl-2; NSO-Bcl-2; NSO-bcl2; NS0-bcl2
DR   Wikidata; Q54931048
RX   Patent=US5565337;
RX   PubMed=8202525;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11705.
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC   Transfected with: HGNC; 990; BCL2.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse plasma cell myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
SX   Female
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
RX   Patent=US5565337;
RA   Diamond B.A., Ray S.;
RT   "Hybridoma-producing NSO myeloma cell line.";
RL   Patent number US5565337, 15-Oct-1996.
//
RX   PubMed=8202525; DOI=10.1073/pnas.91.12.5548;
RA   Ray S., Diamond B.A.;
RT   "Generation of a fusion partner to sample the repertoire of splenic B
RT   cells destined for apoptosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:5548-5551(1994).
//